rs5030826

Variant summary

Our verdict is Pathogenic. The variant received 22 ACMG points: 22P and 0B. PVS1PS3PM2PP5_Very_Strong

The NM_000551.4(VHL):​c.194C>A​(p.Ser65*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV006462985: "This variant was determined to be functionally deleterious in one saturation genome editing assay (Buckley M et al. Nat Genet, 2024 Jul" and additional evidence is available in ClinVar. Synonymous variant affecting the same amino acid position (i.e. S65S) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: not found (cov: 33)

Consequence

VHL
NM_000551.4 stop_gained

Scores

3
3

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:6

Conservation

PhyloP100: 4.92

Publications

66 publications found
Variant links:
Genes affected
VHL (HGNC:12687): (von Hippel-Lindau tumor suppressor) This gene encodes a component of a ubiquitination complex. The encoded protein is involved in the ubiquitination and degradation of hypoxia-inducible-factor (HIF), which is a transcription factor that plays a central role in the regulation of gene expression by oxygen. In addition to oxygen-related gene expression, this protein plays a role in many other cellular processes including cilia formation, cytokine signaling, regulation of senescence, and formation of the extracellular matrix. Variants of this gene are associated with von Hippel-Lindau syndrome, pheochromocytoma, erythrocytosis, renal cell carcinoma, and cerebellar hemangioblastoma. [provided by RefSeq, Jun 2022]
VHL Gene-Disease associations (from GenCC):
  • pheochromocytoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • von Hippel-Lindau disease
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen, Genomics England PanelApp, G2P
  • renal cell carcinoma
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • autosomal recessive secondary polycythemia not associated with VHL gene
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics
  • Chuvash polycythemia
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
  • hereditary pheochromocytoma-paraganglioma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 22 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PS3
PS3 evidence extracted from ClinVar submissions: SCV006462985: "This variant was determined to be functionally deleterious in one saturation genome editing assay (Buckley M et al. Nat Genet, 2024 Jul;56:1446-1455)."
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 3-10142041-C-A is Pathogenic according to our data. Variant chr3-10142041-C-A is described in ClinVar as Pathogenic. ClinVar VariationId is 223161.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000551.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VHL
NM_000551.4
MANE Select
c.194C>Ap.Ser65*
stop_gained
Exon 1 of 3NP_000542.1A0A024R2F2
VHL
NM_001354723.2
c.194C>Ap.Ser65*
stop_gained
Exon 1 of 3NP_001341652.1A0A8Q3WL21
VHL
NM_198156.3
c.194C>Ap.Ser65*
stop_gained
Exon 1 of 2NP_937799.1A0A0S2Z4K1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VHL
ENST00000256474.3
TSL:1 MANE Select
c.194C>Ap.Ser65*
stop_gained
Exon 1 of 3ENSP00000256474.3P40337-1
VHL
ENST00000345392.3
TSL:1
c.194C>Ap.Ser65*
stop_gained
Exon 1 of 2ENSP00000344757.2P40337-2
VHL
ENST00000477538.2
TSL:1
n.240C>A
non_coding_transcript_exon
Exon 1 of 3

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
32
GnomAD4 genome
Cov.:
33

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
2
-
-
Von Hippel-Lindau syndrome (2)
1
-
-
Chuvash polycythemia (1)
1
-
-
Hereditary cancer-predisposing syndrome (1)
1
-
-
not provided (1)
1
-
-
Von Hippel-Lindau syndrome;C1837915:Chuvash polycythemia (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.62
D
BayesDel_noAF
Pathogenic
0.63
CADD
Pathogenic
36
DANN
Uncertain
0.99
Eigen
Uncertain
0.66
Eigen_PC
Uncertain
0.49
FATHMM_MKL
Pathogenic
0.99
D
PhyloP100
4.9
Vest4
0.88
GERP RS
4.7
PromoterAI
-0.11
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=2/198
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5030826; hg19: chr3-10183725; COSMIC: COSV56543035; COSMIC: COSV56543035; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.